Catecholamines stimulate the proliferation and alkaline phosphatase activity of MC3T3-E1 osteoblast-like cells

Bone

Volumn 23, Issue 3, 1998, Pages 197-203

  Suzuki, A ^a   Palmer, G ^a   Bonjour, J P ^a   Caverzasio, Joseph ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Alkaline phosphatase; Epinephrine; Guanosine 5' triphosphate (GTP) binding protein; Osteoblasts; Proliferation; Tyrosine kinase

Indexed keywords

ADRENALIN; ALKALINE PHOSPHATASE; ALPHA 1 ADRENERGIC RECEPTOR; CATECHOLAMINE DERIVATIVE; GENISTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; NORADRENALIN; OSTEOCALCIN; PERTUSSIS TOXIN; PHENOXYBENZAMINE; PROPRANOLOL; RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DIVISION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; MITOGENESIS; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN PHOSPHORYLATION;

3T3 CELLS; ADRENERGIC ALPHA-AGONISTS; ALKALINE PHOSPHATASE; ANIMALS; CATECHOLAMINES; CELL DIFFERENTIATION; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; GTP-BINDING PROTEINS; ISOPROTERENOL; MICE; NOREPINEPHRINE; OSTEOBLASTS; PERTUSSIS TOXIN; VIRULENCE FACTORS, BORDETELLA;

EID: 0031690011     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(98)00099-4     Document Type: Article

References (25)

1. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., and Fukami, Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595; 1987.
2. Bjurholm, A., Kreicbergs, A., Schultzberg, M., and Lerner, U. H. Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and SaOs-2) and primary bone cells. J Bone Miner Res 7:1011-1019; 1992.
3. Canalis, E. Growth factors, bone metabolism, and metabolic bone diseases. Endocrinologist 6:89-94; 1996.
4. Caverzasio, J., Imai, T., Ammann, P., Burgener, D., and Bonjour, J.-P. Aluminum potentiates the effect of fluoride on tyrosine phosphorylation and osteoblast replication in vitro and bone mass in vivo. J Bone Miner Res 11:46-55; 1996.
5. Caverzasio, J., Palmer, G., Suzuki, A., and Bonjour, J.-P. Mechanism of the mitogenic effect of fluoride on osteoblast-like cells: Evidences for a G protein-dependent tyrosine phosphorylation process. J Bone Miner Res 12:1975-1983; 1997.
6. Farley, J. R., Hall, A. L., Herring, S., and Tarbaux, N. M. Two biochemical indices of mouse bone formation are increased, in vivo, in response to calcitonin. Calcif Tissue Int 50:67-73; 1992.
7. 1-adrenoceptor classification: Sharpening Occam's razor. Trends Pharmacol Sci 15:167-170; 1994.
8. Hedler, L., Stamm, G., Weitzell, R., and Starke, K. Functional characterization of central α-adrenoceptors by yohimbine diastereomers. Eur J Pharmacol 70:43-52; 1981.
9. Hoeffel, J. C., Diard, F., Loirat, C., Worms, A. M., and Schmitt, M. Bone lesions secondary to benign pheochromocytoma. J Bone Joint Surg (Br) 73-B:158-161; 1991.
10. Hoffman, B. B. and Lefkowitz, R. J. Chatecholamines and sympathomimetic drugs. In: Gilman, A. G., Rall, T. W., Nies, A. S., and Taylor, P., Eds. The Pharmacological Basis of Therapeutics. New York: Pergamon; 1990; 187-220.
11. Insel, P. A. Adrenergic receptors, G proteins, and cell regulation: Implications for aging research. Exp Gerontol 28:341-348; 1993.
12. Johnson, G. L., Gardner, A. M., Lange-Carter, C., Qian, N.-X., Russell, M., and Winitz, S. How does the G protein, Gi2, transduce mitogenic signals? J Cell Biochem 54:415-422; 1994.
13. Kusaka, M., Oshima, T., Yokota, K., Yamamoto, S., and Kumegawa, M. Possible induction of fatty acid cyclooxygenase in mouse osteoblastic cells (MC3T3-E1) by cAMP. Biochim Biophys Acta 972:339-346; 1988.
14. Lowry, O. H., Roberts, N. R., Wu, M. L., Hixon, W. S., and Crawford, E. J. The quantitative histochemistry of brain. II. Enzyme measurements. J Biol Chem 207:19-37; 1954.
15. Malarkey, K., Belham, C. M., Paul, A., Graham, A., McLees, A., Scott, P. H., and Plevin, R. The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors. Biochem J 309:361-375; 1995.
16. 1A antagonists. J Pharmacol Exp Ther 268:337-352; 1994.
17. Mimura, Y., Kobayashi, S., Notoya, K., Okabe, M., Kimura, I., Horikoshi, I., and Kimura, M. Activation by α1-adrenergic agonists of the progression phase in the proliferation of primary cultures of smooth muscle cells in mouse and rat aorta. Biol Pharm Bull 18:1373-1376; 1995.
18. Moore, R. E., Smith II, C. K., Bailey, C. S., Voelkel, E. F., and Tashijian, Jr., A. H. Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture. Bone Miner 23:301-315; 1993.
19. 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Mol Pharmacol 37:30-36; 1989.
20. Neer, E. J. Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80:249-257; 1995.
21. Oshima, T., Yoshimoto, T., Yamamoto, S., Kumegawa, M., Yokoyama, C., and Tanabe, T. cAMP-dependent induction of fatty acid cyclooxygenase mRNA in mouse osteoblastic cells (MC3T3-E1). J Biol Chem 266:13621-13626; 1991.
22. Quarles, L. D. and Siddhanti, S. R. Guanine nucleotide binding-protein coupled signaling pathway regulation of osteoblast-mediated bone formation. J Bone Miner Res 11:1375-1383; 1996.
23. Rodan, S. B. and Rodan, G. A. The effect of parathyroid hormone and thyrocalcitonin on the accumulation of cyclic adenosine 3′:5′-monophosphate in freshly isolated bone cells. J Biol Chem 249:3068-3074; 1974.
24. 2-adrenoreceptor antagonists. J Med Chem 29:1780-1783; 1986.
25. Van Biesen, T., Luttrell, L. M., Hawes, B. E., and Lefkowitz, R. J. Mitogenic signaling via G protein-coupled receptors. Endocrin Rev 17:698-714; 1996.